MedTrace Logo

To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects

NCT07036458 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2026-04-23

No results posted yet for this study

Summary

To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects

Conditions

  • Healthy Male Adults

Interventions

DRUG

14C Epaminurad Oral Solution

Subjects will receive a single administration of 14C Epaminurad Oral Solution

Sponsors & Collaborators

Principal Investigators

  • McKenzie Litza, Principal Investigator · Quotient Sciences

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-22
Primary Completion
2025-09-05
Completion
2025-09-05

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07036458 on ClinicalTrials.gov